RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy prior to resection of colorectal liver metastases

PURPOSE: RAS mutations have been reported to be a potential prognostic factor in patients with colorectal liver metastases (CLM). However, the impact of RAS mutations on response to chemotherapy remains unclear. We sought to determine the association between RAS mutations and response to preoperativ...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Surg Oncol
Hlavní autoři: Zimmitti, Giuseppe, Shindoh, Junichi, Mise, Yoshihiro, Kopetz, Scott, Loyer, Evelyne M., Andreou, Andreas, Cooper, Amanda B., Kaur, Harmeet, Aloia, Thomas A., Maru, Dipen M., Vauthey, Jean-Nicolas
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4318708/
https://ncbi.nlm.nih.gov/pubmed/25227306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-014-4042-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky